Delisting risk
Cellectar Biosciences
Develops targeted radiotherapeutics for cancer through a phospholipid drug conjugate platform.
$2.60
After-hours close+0.09 (+3.39%)
At close$2.51(−0.99%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.56 | — | — |
| Aug 2026 | −$0.52 | −$0.57 | −9.6% |
| May 2026 | −$1.89 | −$1.33 | +29.4% |
| Mar 2026 | −$1.19 | −$0.53 | +55.5% |
| Nov 2025 | −$1.91 | −$1.41 | +26.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 12, 2026 | −$0.56 | — | — | $17.0M | — | — |
| Aug 13, 2026 | −$0.52 | −$0.57 | −9.6% | $12.0M | — | — |
| May 14, 2026 | −$1.89 | −$1.33 | +29.4% | $8.0M | — | — |
| Mar 4, 2026 | −$1.19 | −$0.53 | +55.5% | $12.8M | — | — |
| Nov 13, 2025 | −$1.91 | −$1.41 | +26.2% | — | — | — |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 14, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 13, 2025 | ||||||
| Nov 18, 2024 | ||||||
| Oct 29, 2024 | ||||||
| Aug 13, 2024 | ||||||
| May 14, 2024 | ||||||
| Mar 27, 2024 | ||||||
| Nov 13, 2023 | ||||||
| Aug 14, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 9, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 5, 2022 | ||||||
| May 10, 2022 | ||||||
| Mar 21, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 2, 2021 | ||||||
| Nov 9, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 7, 2020 | ||||||
| Mar 9, 2020 | ||||||
| Nov 12, 2019 | ||||||
| Aug 12, 2019 | ||||||
| May 6, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 13, 2018 | ||||||
| Aug 10, 2018 | ||||||
| May 11, 2018 | ||||||
| Mar 21, 2018 | ||||||
| Nov 9, 2017 | ||||||
| Aug 14, 2017 | ||||||
| May 11, 2017 | ||||||
| Mar 15, 2017 | ||||||
| Nov 10, 2016 | ||||||
| Aug 11, 2016 | ||||||
| May 12, 2016 | ||||||
| Mar 11, 2016 | ||||||
| Nov 12, 2015 | ||||||